INMUNE BIO INC. Operating Leases, Future Minimum Payments, Due in Four and Five Years
INMUNE BIO INC. (INMB) had Operating Leases, Future Minimum Payments, Due in Four and Five Years of $199.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears · last filed 2022-03-03
- 2021-12-31: Operating Leases, Future Minimum Payments, Due in Four and Five Years $199.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four and Five Years |
|---|---|
| 2021-12-31 | $199.00K 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |